The company anouncement on 05/09/2011 regarding Notice of General Meeting to be held on 7 October 2011 states on page 8:
USE OF FUNDS (Re capital raising) approx that;
10% will be used to further the company's Italian and French trial on non-evasive diagnostic test for the detection of breast cancer.
30% toward the identification of any potential new businesses, and the balance
60% for working capital.
They plan to spend 3x more on potential new businesses that further tests re Italian and French trials.
This I believe along with the appointmet of the two new directors (who both have had extensive involvement not in the Medical field but in the Resource Sector), is a strong indication of the future plans of the company.
Nothing else makes sense IMO.
Yes I hold.
- Forums
- ASX - By Stock
- FER
- what is the stocks future?
what is the stocks future?
Featured News
Add FER (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online